Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-107413
Filing Date
2016-03-24
Accepted
2016-03-24 16:03:22
Documents
1
Period of Report
2016-03-22

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4115
  Complete submission text file 0001104659-16-107413.txt   5455
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations

Mailing Address 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010
Business Address
Verner Erik J. (Reporting) CIK: 0001664488 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37719 | Film No.: 161527078